Mereo BioPharma Group plc (LON:0A9G)
London
· Delayed Price · Currency is GBP · Price in USD 2.805
-0.014 (-0.50%)
At close: Jun 20, 2025
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of 322.69 million as of June 23, 2025. Its market cap has decreased by -11.52% in one year.
Market Cap
322.69M
Enterprise Value
276.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.81
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from 96.41M to 322.69M, an increase of 234.70%. That is a compound annual growth rate of 21.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.58B |
| Shell | 158.90B |
| HSBC Holdings | 149.23B |
| Unilever | 114.05B |
| British American Tobacco p.l.c. | 79.70B |
| Rolls-Royce Holdings | 74.05B |
| RELX PLC | 71.45B |
| Rio Tinto Group | 70.48B |